The Antibiotic, Amoxicillin-Clavulanate, Before a Meal May Improve Small Bowel MotilityMay 01, 2012
Amoxicillan-clavulanate, also known as Augmentin, is most commonly prescribed to treat or prevent infections caused by bacteria. However, it has also been reported to increase small bowel motility in healthy individuals and has been used to treat bacterial overgrowth in patients with chronic diarrhea.
Upper gastrointestinal symptoms such as nausea, vomiting, abdominal pain, early satiety and abdominal distention are common in children. Despite the advances in the technology for diagnosing motility disorders, there continues to be a lack of medications available for the treatment of upper gastrointestinal tract motor function.
"There is a significant need for new drugs to treat upper gastrointestinal symptoms in children," said Carlo Di Lorenzo, MD, chief of Gastroenterology, Hepatology and Nutrition at Nationwide Children's Hospital and one of the study authors. "Currently used drugs are often only available on a restricted basis, have significant side effects or aren't effective enough on the small and large intestine."
To examine whether amoxicillin-clavulanate might serve as a new option for treating upper gastrointestinal tract motor function, investigators at Nationwide Children's examined 20 patients who were scheduled to undergo antroduodenal manometry testing. After catheter placement, the team monitored each child's motility during fasting for at least three hours. The children then received one dose of amoxicillin-clavulanate enterally, either one hour before ingestion of a meal or one hour after the meal and then had motility monitored for one hour following.
The study showed that amoxicillin-clavulanate triggered groups of propagated contractions within the small intestine, similar to those observed during the duodenal phase III of the interdigestive motility process. This response occurred in most of the study participants during the first 10-20 minutes and was most evident when amoxicillin-clavulanate was given before the meal.
"Inducing a preprandial duodenal phase III may accelerate small bowel transit, influence the gut microbiome and play a role in preventing the development of small bowel bacterial overgrowth," said Dr. Di Lorenzo.
Dr. Di Lorenzo says that amoxicillin-clavulanate may be most effective in patients with alterations of duodenal phase III, chronic symptoms of intestinal pseudo-obstruction and those fed directly into the small bowel with gastrojejunal nasojejunal feeding tubes or surgical jejunostomy.
Although amoxicillin-clavulanate seems to mainly affect the small bowel, the mechanisms by which it works are not clear. Dr. Di Lorenzo also says that possible downsides of using amoxicillin-clavulanate as a prokinetic agent include the induction of bacterial resistance, especially from gram negative bacteria such as E.coli and Klebsiella and causing Clostridium difficile induced colitis.
Still, he says further investigation of amoxicillin-clavulanate's long-term benefits in gastrointestinal clinical situations is worthwhile. "The scarcity of currently available therapeutic options may justify the use of amoxicillin-clavulanate in selected patients with severe forms of small bowel dysmotility in whom other interventions have not been efficacious," he said.
Nationwide Children's Hospital
Related Amoxicillin-clavulanate Current Events and Amoxicillin-clavulanate News Articles
Findings suggest antivirals underprescribed for patients at risk for flu complications
Patients likely to benefit the most from antiviral therapy for influenza were prescribed these drugs infrequently during the 2012-2013 influenza season, while antibiotics may have been overprescribed.
Antibiotic therapy improves moderate exacerbations of mild-to-moderate COPD
Antibiotic treatment with amoxicillin/clavulanate improves moderate exacerbations in patients with mild-to-moderate chronic obstructive pulmonary disease (COPD) and significantly prolongs the time between exacerbations, according to a new study from researchers in Spain.
Antimicrobial resistance for common UTI drug increases five fold since 2000
In a surveillance study of over 12 million bacteria, investigators at The George Washington University and Providence Hospital found E. coli antimicrobial resistance to ciprofloxacin, the most commonly prescribed antimicrobial for urinary tract infections in the U.S., increased over five-fold from 2000 to 2010.
Most sinus infections don't require antibiotics
The vast majority of sinus infections are caused by viruses and should not be treated with antibiotics, suggest new guidelines released by the Infectious Diseases Society of America (IDSA).
UNC launches study of liver injury caused by drugs
The University of North Carolina at Chapel Hill is one of five clinical centers nationwide to receive funds from the National Institutes of Health to study why good medications are sometimes bad for the liver.
More Amoxicillin-clavulanate Current Events and Amoxicillin-clavulanate News Articles